JPRN-UMIN000001017Completed未知
Therapeutic effect of pioglitazone on chronic kidney disease (CKD). - Treatment of CKD by pioglitazone.
ational Defense Medical College0 sites24 target enrollmentStarted: February 27, 2008Last updated:
Trial Snapshot
- Phase
- 未知
- Status
- Completed
- Sponsor
- Enrollment
- 24
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 20years-old to 85years-old (—)
- Sex
- All
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1. Chronic renal failure with serum creatinine level above 3.0 mg/dl. 2. Severe liver dysfunction. 3. Severe edema or chronic heart failure. 4. Past history of allergy against pioglitazone. 5. Pregnant or breast feeding patients. 6. Patients with ongoing steroid therapy.
Investigators
Similar Trials
Completed
Not Applicable
Effect of pioglitazone on renal function amelioration by measurement of cystatine C levels in the type 2 diabetic patientsDiabetic nephropathyJPRN-UMIN000000689Department of Endocrinology and Diabetes, Nagoya University Graduate School of Medicine70
Not yet recruiting
Not Applicable
ong-term therapeutic effect of pioglitazone on chronic kidney disease (CKD)JPRN-UMIN000004071ational Defense Medical College50
Active, not recruiting
Not Applicable
Influence of pioglitazone for renal transplant function in diabeticsnephropathy after renal transplantation in patients with type 2 diabetesMedDRA version: 8.1Level: LLTClassification code 10061835Term: Diabetic nephropathyEUCTR2006-004467-65-DETechnical University Dresden
Completed
Phase 3
Effect of a lowering blood glucose drug on protein loss with urine in patient with kidney disease due to diabetDiabetic nephropathy.Diabetes mellitus With renal complicationsE10-E14 :IRCT2013102115105N1Vice chancellor for research, Tabriz University of Medical Sciences60
Active, not recruiting
Not Applicable
Effect of pioglitazone in patienst with Adrenomyeloneuropathy.X-linked adrenoleukodystrophyEUCTR2011-006113-34-ESAURORA PUJOL ONOFRE